BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND CEACAM5, CEA AND Prognosis
44 results:

  • 1. Construction of the survival nomograms for colon cancer patients of different ages based on the SEER database.
    Yang Y; Xu P; Zhang C
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15395-15406. PubMed ID: 37639008
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of High-Versus Low-Frequency of Abdominopelvic Computed Tomography Follow-Up Testing on Overall Survival in Patients With Stage II Or III Colon cancer.
    Jeon J; Lee DB; Shin SJ; Han DH; Chang JS; Han YD; Kim H; Lim JS; Kim HS; Ahn JB
    Clin Colorectal Cancer; 2023 Sep; 22(3):307-317. PubMed ID: 37271592
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic impact of tumor size on patients with metastatic colorectal cancer: a large SEER-based retrospective cohort study.
    Zhang Q; Li B; Zhang S; Huang Q; Zhang M; Liu G
    Updates Surg; 2023 Aug; 75(5):1135-1147. PubMed ID: 37202599
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Assessing the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Stage I Non-Small-Cell Lung cancer with Complete Resection.
    Liu W; Zhang T; Li L; Zou J; Xu C
    Can Respir J; 2022; 2022():6837872. PubMed ID: 35782962
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The joint detection of cea and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.
    Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S
    J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Homogeneous and heterogeneous risk and prognostic factors for lung metastasis in colorectal cancer patients.
    Wang H; Shan X; Zhang M; Qian K; Shen Z; Zhou W
    BMC Gastroenterol; 2022 Apr; 22(1):193. PubMed ID: 35436849
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nomogram for predicting overall survival in colorectal cancer with distant metastasis.
    Liu Z; Xu Y; Xu G; Baklaushev VP; Chekhonin VP; Peltzer K; Ma W; Wang X; Wang G; Zhang C
    BMC Gastroenterol; 2021 Mar; 21(1):103. PubMed ID: 33663400
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
    He J; Wang X; Xiao R; Zuo W; Zhang W; Yao H
    Medicine (Baltimore); 2021 Mar; 100(9):e24724. PubMed ID: 33655937
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Trousseau Syndrome Related Cerebral Infarction: Clinical Manifestations, Laboratory Findings and Radiological Features.
    Bao L; Zhang S; Gong X; Cui G
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104891. PubMed ID: 32807409
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.
    Yang Y; Lu Y; Jiang W; Zhu J; Yan S
    World J Surg Oncol; 2020 Aug; 18(1):193. PubMed ID: 32746835
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nomogram to predict the risk and survival of synchronous bone metastasis in colorectal cancer: a population-based real-world analysis.
    Han L; Dai W; Mo S; Xiang W; Li Q; Xu Y; Wang R; Cai G
    Int J Colorectal Dis; 2020 Aug; 35(8):1575-1585. PubMed ID: 32417937
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis.
    Wang J; Li S; Liu Y; Zhang C; Li H; Lai B
    Cancer Med; 2020 Jan; 9(1):361-373. PubMed ID: 31693304
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Lung Metastasis Predicts Better prognosis in Metastatic Colorectal cancer With Mutated KRAS.
    Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Giantonio B; Boursi B
    Clin Colorectal Cancer; 2019 Sep; 18(3):e300-e307. PubMed ID: 31324478
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A clinical model to predict the risk of synchronous bone metastasis in newly diagnosed colorectal cancer: a population-based study.
    Guan X; Ma CX; Quan JC; Li S; Zhao ZX; Chen HP; Yang M; Liu Z; Jiang Z; Wang XS
    BMC Cancer; 2019 Jul; 19(1):704. PubMed ID: 31315606
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pulmonary metastasis in newly diagnosed colon-rectal cancer: a population-based nomogram study.
    Huang Y; Zhao M; Yin J; Lu T; Yang X; Yuan G; Li M; Liu Y; Zhan C; Wang Q
    Int J Colorectal Dis; 2019 May; 34(5):867-878. PubMed ID: 30854572
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
    Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
    BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
    Stewart CL; Warner S; Ito K; Raoof M; Wu GX; Kessler J; Kim JY; Fong Y
    Curr Probl Surg; 2018 Sep; 55(9):330-379. PubMed ID: 30526930
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
    Ramos-Gomes F; Bode J; Sukhanova A; Bozrova SV; Saccomano M; Mitkovski M; Krueger JE; Wege AK; Stuehmer W; Samokhvalov PS; Baty D; Chames P; Nabiev I; Alves F
    Sci Rep; 2018 Mar; 8(1):4595. PubMed ID: 29545609
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.
    Wu X; Ma W; Zhou Q; Yan H; Lim ZF; Huang M; Deng C; Yu X; Su H; Komo S; Yang H; Zhang X; Wen S; Zhang Z; Ma PC
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1947-1957. PubMed ID: 28551766
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.
    Darlix A; Lamy PJ; Lopez-Crapez E; Braccini AL; Firmin N; Romieu G; Thezenas S; Jacot W
    BMC Cancer; 2016 Jul; 16():428. PubMed ID: 27387327
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.